| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.4B |
| EPS (Basic) | $0.91 | $0.92 | $0.27 | $0.83 | $1.42 | $0.89 | $0.91 | $3.80 |
| EPS (Diluted) | $0.90 | $0.91 | $0.27 | $0.82 | $1.41 | $0.89 | $0.91 | $3.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.0B | $35.2B | $35.8B | $37.0B | $35.8B | $35.0B | $32.9B | $30.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.5B | $0.6B | $0.6B | $0.3B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $32.0B | $32.4B | $33.2B | $34.6B | $32.8B | $32.0B | $29.9B | $27.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.1B | $2.8B | $2.6B | $2.4B | $3.0B | $3.0B | $3.0B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.7B | $1.3B | $1.2B | $0.9B | $0.6B | $0.3B |
| Investing Cash Flow | $-0.2B | $0.4B | $1.0B | $-2.1B | $-1.6B | $-2.6B | $-1.1B | $-2.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.9B | $-1.6B | $1.1B | $0.3B | $1.9B | $0.3B | $1.9B |